Chronic pancreatitis

Current Opinion in Gastroenterology

Volumn 28, Issue 5, 2012, Pages 523-531

  Dimagno, Matthew J ^a   Dimagno, Eugene P ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

chronic pancreatitis; diabetes mellitus; exocrine pancreatic insufficiency; pain

Indexed keywords

ALCOHOL; PANCRELIPASE; PREGABALIN; UNCLASSIFIED DRUG; VOIKACE;

ALCOHOL CONSUMPTION; CHRONIC PANCREATITIS; CIGARETTE SMOKING; DIABETES MELLITUS; DISEASE COURSE; GENE MUTATION; HUMAN; INCIDENCE; NEUROPATHIC PAIN; PAIN; PANCREAS EXOCRINE INSUFFICIENCY; PREVALENCE; REVIEW; RISK FACTOR; STEATORRHEA; UNFOLDED PROTEIN RESPONSE;

ABDOMINAL PAIN; BINGE DRINKING; DIABETES MELLITUS; DRAINAGE; EXOCRINE PANCREATIC INSUFFICIENCY; HUMANS; PAIN MANAGEMENT; PANCREATITIS; PANCREATITIS, CHRONIC; SMOKING; UNFOLDED PROTEIN RESPONSE;

EID: 84865499063     PISSN: 02671379     EISSN: 15317056     Source Type: Journal    
DOI: 10.1097/MOG.0b013e3283567dea     Document Type: Review

References (93)

1. Yadav D, Timmons L, Benson JT, et al. Incidence, prevalence, and survival of chronic pancreatitis: a population-based study. Am J Gastroenterol 2011; 106:2192-2199.
2. Sadr-Azodi O, Andren-Sandberg A, Orsini N, et al. Cigarette smoking, smoking cessation and acute pancreatitis: a prospective population-based study. Gut 2012; 61:262-267.
3. Nojgaard C, Becker U, Matzen P, et al. Progression from acute to chronic pancreatitis: prognostic factors, mortality, and natural course. Pancreas 2011; 40:1195-1200.
4. Moreau JA, Zinsmeister AR, Melton LJ 3rd, et al. Gallstone pancreatitis and the effect of cholecystectomy: a population-based cohort study. Mayo Clin Proc 1988; 63:466-473.
5. Phillip V, Huber W, Hagemes F, et al. Incidence of acute pancreatitis does not increase during Oktoberfest, but is higher than previously described in Germany. Clin Gastroenterol Hepatol 2011; 9:995-1000.
6. DiMagno MJ. Oktoberfest binge drinking and acute pancreatitis. Is there really no relationship? Clin Gastroenterol Hepatol 2011; 9:920-922.
7. Friedreich N. Diseases of the pancreas. In: Ziemssen H, editor. Cyclopedia of the Practice of Medicine. New York: William Wood; 1878. pp. 549-630.
8. Lankisch PG, Lowenfels AB, Maisonneuve P. What is the risk of alcoholic pancreatitis in heavy drinkers? Pancreas 2002; 25:411-412. (Pubitemid 35247222)
9. Yadav D, Eigenbrodt ML, Briggs MJ, et al. Pancreatitis: prevalence and risk factors among male veterans in a detoxification program. Pancreas 2007; 34:390-398. (Pubitemid 46725778)
10. Durbec JP, Sarles H. Multicenter survey of the etiology of pancreatic diseases. Relationship between the relative risk of developing chronic pancreatitis and alcohol, protein and lipid consumption. Digestion 1978; 18:337-350. (Pubitemid 9182802)
11. Stigendal L, Olsson R. Alcohol consumption pattern and serum lipids in alcoholic cirrhosis and pancreatitis. A comparative study. Scand J Gastroenterol 1984; 19:582-587. (Pubitemid 14054267)
12. Wilson JS, Bernstein L, McDonald C, et al. Diet and drinking habits in relation to the development of alcoholic pancreatitis. Gut 1985; 26:882-887. (Pubitemid 15229637)
13. Bourliere M, Barthet M, Berthezene P, et al. Is tobacco a risk factor for chronic pancreatitis and alcoholic cirrhosis? Gut 1991; 32:1392-1395.
14. DiMagno MJ, DiMagno EP. Chronic pancreatitis. Curr Opin Gastroenterol 2006; 22:487-497.
15. Lu Z, Karne S, Kolodecik T, et al. Alcohols enhance caerulein-induced zymogen activation in pancreatic acinar cells. Am J Physiol Gastrointest Liv Physiol 2002; 282:G501-G507. (Pubitemid 34651665)
16. Gukovsky I, Lugea A, Shahsahebi M, et al. A rat model reproducing key pathological responses of alcoholic chronic pancreatitis. Am J Physiol Gastrointest Liver Physiol 2008; 294:G68-G79.
17. Pandol SJ, Periskic S, Gukovsky I, et al. Ethanol diet increases the sensitivity of rats to pancreatitis induced by cholecystokinin octapeptide. Gastroenterology 1999; 117:706-716. (Pubitemid 29409258)
18. Vonlaufen A, Xu Z, Daniel B, et al. Bacterial endotoxin: a trigger factor for alcoholic pancreatitis? Evidence from a novel, physiologically relevant animal model. Gastroenterology 2007; 133:1293-1303. (Pubitemid 47494445)
19. Lugea A, Tischler D, Nguyen J, et al. Adaptive unfolded protein response attenuates alcohol-induced pancreatic damage. Gastroenterology 2011; 140:987-997.
20. Hess DA, Humphrey SE, Ishibashi J, et al. Extensive pancreas regeneration following acinar-specific disruption of Xbp1 in mice. Gastroenterology 2011; 141:1463-1472.
21. DiMagliano MP. Pancreatic stress and regeneration. Gastroenterology 2011; 141:1155-1158.
22. Aoun E, Muddana V, Papachristou GI, et al. SPINK1 N34S is strongly associated with recurrent acute pancreatitis but is not a risk factor for the first or sentinel acute pancreatitis event. Am J Gastroenterol 2010; 105:446-451.
23. Pezzilli R, Morselli-Labate AM, Mantovani V, et al. Mutations of the CFTR gene in pancreatic disease. Pancreas 2003; 27:332-336. (Pubitemid 37337900)
24. Masamune A, Ariga H, Kume K, et al. Genetic background is different between sentinel and recurrent acute pancreatitis. J Gastroenterol Hepatol 2011; 26:974-978.
25. Zhang L, Chari S, Smyrk TC, et al. Autoimmune pancreatitis (AIP) type 1 and type 2: an international consensus study on histopathologic diagnostic criteria. Pancreas 2011; 40:1172-1179.
26. Deshpande V, Gupta R, Sainani N, et al. Subclassification of autoimmune pancreatitis: a histologic classification with clinical significance. Am J Surg Pathol 2011; 35:26-35.
27. Song TJ, Kim JH, Kim MH, et al. A comparison of clinical findings between histologically confirmed type 1 and type 2 autoimmune pancreatitis. J Gastroenterol Hepatol 2012; 27:700-708.
28. Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol 2012; 22:21-30.
29. Iwashita T, Yasuda I, Doi S, et al. Use of samples from endoscopic ultrasoundguided 19-gauge fine-needle aspiration in diagnosis of autoimmune pancreatitis. Clin Gastroenterol Hepatol 2012; 10:316-322.
30. Imai K, Matsubayashi H, Fukutomi A, et al. Endoscopic ultrasonographyguided fine needle aspiration biopsy using 22-gauge needle in diagnosis of autoimmune pancreatitis. Dig Liv Dis 2011; 43:869-874.
31. Khalid A, Dewitt J, Ohori NP, et al. EUS-FNA mutational analysis in differentiating autoimmune pancreatitis and pancreatic cancer. Pancreatology 2011; 11:482-486.
32. Sugumar A, Levy MJ, Kamisawa T, et al. Endoscopic retrograde pancreatography criteria to diagnose autoimmune pancreatitis: an international multicenter study. Gut 2011; 60:666-670.
33. Chandrasekhara V, Ahmad NA. Diagnostic endoscopic retrograde pancreatography for autoimmune pancreatitis: one size does not fit all. Gastroenterology 2012; 142:180-182.
34. Kim JH, Kim MH, Byun JH, et al. Diagnostic strategy for differentiating autoimmune pancreatitis from pancreatic cancer: is an endoscopic retrograde pancreatography essential? Pancreas 2012. [Epub ahead of print]
35. Rebours V, Le Baleur Y, Cazals-Hatem D, et al. Immunoglobulin G4 immunostaining of gastric, duodenal, or colonic biopsies is not helpful for the diagnosis of autoimmune pancreatitis. Clin Gastroenterol Hepatol 2012; 10:91-94.
36. Agrawal S, Daruwala C, Khurana J. Distinguishing autoimmune pancreatitis from pancreaticobiliary cancers: current strategy. Ann Surg 2012; 255:248-258.
37. Psarras K, Baltatzis ME, Pavlidis ET, et al. Autoimmune pancreatitis versus pancreatic cancer: a comprehensive review with emphasis on differential diagnosis. Hepatobil Panc Dis Internat 2011; 10:465-473.
38. Alswat K, Al-Harthy N, Mazrani W, et al. The spectrum of sclerosing cholangitis and the relevance of IgG4 elevations in routine practice. Am J Gastroenterol 2012; 107:56-63.
39. Maruyama M, Arakura N, Ozaki Y, et al. Risk factors for pancreatic stone formation in autoimmune pancreatitis over a long-term course. J Gastroenterol 2011. [Epub ahead of print]
40. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2012; 35 (Suppl 1):S64-S71.
41. Bank S, Marks IN, Vinik AI. Clinical and hormonal aspects of pancreatic diabetes. Am J Gastroenterol 1975; 64:13-22.
42. Joffe BI, Bank S, Jackson WP, et al. Insulin reserve in patients with chronic pancreatitis. Lancet 1968; 2:890-892.
43. Cavallini G, Vaona B, Bovo P, et al. Diabetes in chronic alcoholic pancreatitis. Role of residual beta cell function and insulin resistance. Dig Dis Sci 1993; 38:497-501. (Pubitemid 23087125)
44. Brunicardi FC, Chaiken RL, Ryan AS, et al. Pancreatic polypeptide administration improves abnormal glucose metabolism in patients with chronic pancreatitis. J Clin Endocrinol Metab 1996; 81:3566-3572. (Pubitemid 26339916)
45. Sun YS, Brunicardi FC, Druck P, et al. Reversal of abnormal glucose metabolism in chronic pancreatitis by administration of pancreatic polypeptide. Am J Surg 1986; 151:130-140. (Pubitemid 16143194)
46. Bonora E, Rizzi C, Lesi C, et al. Insulin and C-peptide plasma levels in patients with severe chronic pancreatitis and fasting normoglycemia. Dig Dis Sci 1988; 33:732-736.
47. Wang W, Guo Y, Liao Z, et al. Occurrence of and risk factors for diabetes mellitus in Chinese patients with chronic pancreatitis. Pancreas2011; 40:206-212.
48. Lowenfels AB, Maisonneuve P, Cavallini G, et al. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med 1993; 328:1433-1437. (Pubitemid 23143844)
49. Layer P, Yamamoto H, Kalthoff L, et al. The different courses of early- and lateonset idiopathic and alcoholic chronic pancreatitis. Gastroenterology 1994; 107:1481-1487. (Pubitemid 24328288)
50. Malka D, Hammel P, Sauvanet A, et al. Risk factors for diabetes mellitus in chronic pancreatitis. Gastroenterology 2000; 119:1324-1332.
51. In brief: pancreatic enzyme products. Med Lett Drugs Ther 2011; 7;53:12.
52. Dominguez-Munoz JE. Pancreatic enzyme therapy for pancreatic exocrine insufficiency. Gastroenterol Hepatol 2011; 7:401-403; See reference [53 & ].
53. Dominguez-Munoz JE. Chronic pancreatitis and persistent steatorrhea: what is the correct dose of enzymes? Clin Gastroenterol Hepatol 2011; 9:541-546.
54. DiMagno EP, Go VL, Summerskill WH. Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency. N Engl J Med 1973; 288:813-815.
55. DiMagno EP, Malagelada JR, Go VL, et al. Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedules. N Engl J Med 1977; 296:1318-1322. (Pubitemid 8103698)
56. Regan PT, Malagelada JR, DiMagno EP, et al. Comparative effects of antacids, cimetidine and enteric coating on the therapeutic response to oral enzymes in severe pancreatic insufficiency. N Engl J Med 1977; 297:854-858. (Pubitemid 8200496)
57. Regan PT, Malagelada JR, DiMagno EP, et al. Rationale for the use of cimetidine in pancreatic insufficiency. Mayo Clin Proc 1978; 53:79-83. (Pubitemid 8270016)
58. Regan PT, Malagelada JR, DiMagno EP, et al. Reduced intraluminal bile acid concentrations and fat maldigestion in pancreatic insufficiency: correction by treatment. Gastroenterology 1979; 77:285-289. (Pubitemid 9206039)
59. Whitcomb DC, Lehman GA, Vasileva G, et al. Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: A double-blind randomized trial. Am J Gastroenterol 2010; 105:2276-2286.
60. Gubergrits N, Malecka-Panas E, Lehman GA, et al. A 6-month, open-label clinical trial of pancrelipase delayed-release capsules (Creon) in patients with exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery. Aliment Pharmacol Ther 2011; 33:1152-1161.
61. Toskes PP, Secci A, Thieroff-Ekerdt R. Efficacy of a novel pancreatic enzyme product, EUR-1008 (Zenpep), in patients with exocrine pancreatic insufficiency due to chronic pancreatitis. Pancreas 2011; 40:376-382.
62. Ammann RW, Muellhaupt B. The natural history of pain in alcoholic chronic pancreatitis. Gastroenterology 1999; 116:1132-1140. (Pubitemid 29203023)
63. Mullhaupt B, Truninger K, Ammann R. Impact of etiology on the painful early stage of chronic pancreatitis: a long-term prospective study. Z Gastroenterol 2005; 43:1293-1301. (Pubitemid 43041360)
64. Mullady DK, Yadav D, Amann ST, et al. Type of pain, pain-associated complications, quality of life, disability and resource utilization in chronic pancreatitis: a prospective cohort study. Gut 2011; 60:77-84.
65. Cahen DL, Gouma DJ, Laramee P, et al. Long-term outcomes of endoscopic vs surgical drainage of the pancreatic duct in patients with chronic pancreatitis. Gastroenterology 2011; 141:1690-1695.
66. Stevens T, Costanzo A, Lopez R, et al. Adding triamcinolone to endoscopic ultrasound-guided celiac plexus blockade does not reduce pain in patients with chronic pancreatitis. Clin Gastroenterol Hepatol 2012; 10:186-191.
67. Morgan K, Owczarski SM, Borckardt J, et al. Pain control and quality of life after pancreatectomy with islet autotransplantation for chronic pancreatitis. J Gastrointest Surg 2012; 16:129-133.
68. Bellin MD, Freeman ML, Schwarzenberg SJ, et al. Quality of life improves for pediatric patients after total pancreatectomy and islet autotransplant for chronic pancreatitis. Clin Gastroenterol Hepatol 2011; 9:793-799.
69. Cahen DL, Gouma DJ, Nio Y, et al. Endoscopic versus surgical drainage of the pancreatic duct in chronic pancreatitis. N Engl J Med 2007; 356:676-684.
70. Gress F, Schmitt C, Sherman S, et al. Endoscopic ultrasound-guided celiac plexus block for managing abdominal pain associated with chronic pancreatitis: a prospective single center experience. Am J Gastroenterol 2001; 96:409-416.
71. Madsen P, Hansen E. Coeliac plexus block versus pancreaticogastrostomy for pain in chronic pancreatitis. A controlled randomized trial. Scand J Gastroenterol 1985; 20:1217-1220. (Pubitemid 16192621)
72. Santosh D, Lakhtakia S, Gupta R, et al. Clinical trial: a randomized trial comparing fluoroscopy guided percutaneous technique vs. endoscopic ultrasound guided technique of coeliac plexus block for treatment of pain in chronic pancreatitis. Aliment Pharmacol Ther 2009; 29:979-984.
73. Puli SR, Reddy JB, Bechtold ML, et al. EUS-guided celiac plexus neurolysis for pain due to chronic pancreatitis or pancreatic cancer pain: a meta-analysis and systematic review. Dig Dis Sci 2009; 54:2330-2337.
74. Kaufman M, Singh G, Das S, et al. Efficacy of endoscopic ultrasound-guided celiac plexus block and celiac plexus neurolysis for managing abdominal pain associated with chronic pancreatitis and pancreatic cancer. J Clin Gastroenterol 2010; 44:127-134.
75. Wilcox CM. Tinkering with a tarnished technique: isn't it time to abandon celiac plexus blockade for the treatment of abdominal pain in chronic pancreatitis? Clin Gastroenterol Hepatol 2012; 10:106-108.
76. Frokjaer JB, Olesen SS, Gram M, et al. Altered brain microstructure assessed by diffusion tensor imaging in patients with chronic pancreatitis. Gut 2011; 60:1554-1562; See reference [77 && ].
77. Frokjaer JB, Bouwense SA, Olesen SS, et al. Reduced cortical thickness of brain areas involved in pain processing in patients with chronic pancreatitis. Clin Gastroenterol Hepatol 2012; 10:434-438.
78. Olesen SS, Bouwense SA, Wilder-Smith OH, et al. Pregabalin reduces pain in patients with chronic pancreatitis in a randomized, controlled trial. Gastroenterology 2011; 141:536-543.
79. Zhu Y, Colak T, Shenoy M, et al. Nerve growth factor modulates TRPV1 expression and function and mediates pain in chronic pancreatitis. Gastroenterology 2011; 141:370-377.
80. Olesen SS, Graversen C, Olesen AE, et al. Randomised clinical trial: pregabalin attenuates experimental visceral pain through sub-cortical mechanisms in patients with painful chronic pancreatitis. Aliment Pharmacol Ther 2011; 34:878-887.
81. Owyang C, DiMagno MJ. Chronic pancreatitis. In: Yamada T, Alpers DH, Kalloo AN, Kaplowitz N, Owyang C, Powell DW, editors. Textbook of Gastroenterology, Fifth ed. Philadelphia: Lippincott Williams and Wilkins; 2009. pp. 1811-1852.
82. Woolf CJ, Safieh-Garabedian B, Ma QP, et al. Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity. Neuroscience 1994; 62:327-331.
83. Paulo JA, Urrutia R, Banks PA, et al. Proteomic analysis of a rat pancreatic stellate cell line using liquid chromatography tandem mass spectrometry (LC-MS/MS). J Proteomics 2011; 75:708-717.
84. Won JH, Zhang Y, Ji B, et al. Phenotypic changes in mouse pancreatic stellate cell Ca2+ signaling events following activation in culture and in a disease model of pancreatitis. Mol Biol Cell 2011; 22:421-436.
85. Treiber M, Neuhofer P, Anetsberger E, et al. Myeloid, but not pancreatic, RelA/ p65 is required for fibrosis in a mouse model of chronic pancreatitis. Gastroenterology 2011; 141:1473-1485.
86. Schwer CI, Stoll P, Goebel U, et al. Effects of hydrogen sulfide on rat pancreatic stellate cells. Pancreas 2012; 41:74-83.
87. Gonzalez AM, Garcia T, Samper E, et al. Assessment of the protective effects of oral tocotrienols in arginine chronic-like pancreatitis. Am J Physiol Gastrointest Liv Physiol 2011; 301:G846-G855.
88. Jiang F, Liao Z, Hu LH, et al. Comparison of antioxidative and antifibrotic effects of alpha-tocopherol with those of tocotrienol-rich fraction in a rat model of chronic pancreatitis. Pancreas 2011; 40:1091-1096.
89. Li XC, Lu XL, Chen HH. alpha-Tocopherol treatment ameliorates chronic pancreatitis in an experimental rat model induced by trinitrobenzene sulfonic acid. Pancreatology 2011; 11:5-11.
90. Wei L, Yamamoto M, Harada M, et al. Treatment with pravastatin attenuates progression of chronic pancreatitis in rat. Lab Invest 2011; 91:872-884.
91. Sakurai T, Kudo M, Fukuta N, et al. Involvement of angiotensin II and reactive oxygen species in pancreatic fibrosis. Pancreatology 2011; 11 (Suppl 2):7-13.
92. Vonlaufen A, Phillips PA, Xu Z, et al. Withdrawal of alcohol promotes regression while continued alcohol intake promotes persistence of LPSinduced pancreatic injury in alcohol-fed rats. Gut 2011; 60:238-246.
93. Li L, Bimmler D, Graf R, et al. PSP/reg inhibits cultured pancreatic stellate cell and regulates MMP/TIMP ratio. Eur J Clin Invest 2011; 41:151-158.